Results were correlated with the PTEN and p53 genomic status determined by fluorescence in-situ hybridization (FISH), with clinico-pathologic data including overall survival and with lung NET diagnostic markers. The gene discussed is PTEN; the disease is lung neuroendocrine neoplasm.